ASBP
Financials
- Market Capitalization 7.9 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4851 |  ERNA Ernexa Therapeutics Inc. - Common Stock | 6.51 USD | +7.43% | +10.53% | +7.96% | +1762.66% | 7.59 M USD | ||
| 4855 |  IMNN Imunon, Inc. - Common Stock | 1.95 USD | -1.02% | -6.70% | 0.00% | -40.00% | 8.19 M USD | ||
| 4861 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.20 USD | +3.70% | +3.96% | -9.68% | -26.32% | 8.07 M USD | ||
| 4866 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.29 USD | -17.14% | -58.57% | -56.72% | -72.12% | 7.63 M USD |
Frequently asked questions about Aspire Biopharma Holdings, Inc. - Common Stock
What is the Aspire Biopharma Holdings, Inc. - Common Stock stock price today?
The current price of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) is 6.1. Over the past 24 hours, the stock has changed by +1.16%. Follow the ASBP chart for real-time price dynamics.
What is the stock ticker of Aspire Biopharma Holdings, Inc. - Common Stock?
Aspire Biopharma Holdings, Inc. - Common Stock trades under the ticker ASBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aspire Biopharma Holdings, Inc. - Common Stock stock going up?
ASBP has changed by +7.96% over the last week, +14.88% over the last month, and +291.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Aspire Biopharma Holdings, Inc. - Common Stock release financial reports?
Yes. You can track Aspire Biopharma Holdings, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Aspire Biopharma Holdings, Inc. - Common Stock net income for the last quarter?
Aspire Biopharma Holdings, Inc. - Common Stock reported net income of -3.22 M for the last quarter. The previous quarter showed -4.71 M, which means net income changed by +31.54%.
What is Aspire Biopharma Holdings, Inc. - Common Stock EBITDA?
Aspire Biopharma Holdings, Inc. - Common Stock EBITDA is -62.28 K, and its EBITDA margin is -219.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aspire Biopharma Holdings, Inc. - Common Stock stock?
You can buy Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aspire Biopharma Holdings, Inc. - Common Stock stock?
Investing in Aspire Biopharma Holdings, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ASBP chart and related analysis on metatrader.com as part of your research.